Searchable abstracts of presentations at key conferences on calcified tissues

ba0005p350 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

Bone mineral density in women with Parkinson’s disease

Povoroznyuk Vladyslav , Bystrytska Maryna , Karaban' Irina , Karasevych Nina

Aim: The aim of the research is to define the bone mineral density in patients, with Parkinson’s disease.Methods: We examined 12 women with Parkinson’s disease and 12 healthy women of appropriate age (average age: −63.6±6.25 vs 62.2±6.83 years, P=0.5). The duration of Parkinson’s disease was at list 5 years. All patients reseived levodopa.Results: BMD of women with Parkinson’s disease wa...

ba0005p360 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

Warfarin use and changes in bone mineral density in the population-based canadian multicentre osteoporosis study (CaMos)

Vaninetti Nadine , Kirkland Susan , Thompson Kara , Theriault Chris , Prior Jerilynn , Kovacs Christopher , Adachi Rick , Towheed Tanveer , Leslie William , Davison K Shawn , Morin Suzanne , Goltzman David , Kaiser Stephanie

Background: Osteocalcin has an important role in bone metabolism. Uncarboxylated osteocalcin predicts risk for hip fracture and lower bone mineral density (BMD). Warfarin inhibits carboxylation of osteocalcin, providing a mechanistic link between warfarin and impaired bone metabolism. Studies examining the relationship between warfarin use and BMD have been inconsistent. The goal of this study was to further characterize this relationship.Population: CaM...

ba0005p366 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and antiosteoporotic response to denosumab therapy: preliminary results

Gifre Laia , Vidal Joan , Ruiz-Gaspa Silvia , Portell Enric , Monegal Ana , Muxi Africa , Guanabens Nuria , Peris Pilar

The aims of this study were to analyze the role of the regulators of bone remodeling, OPG and RANKL, in the bone loss associated with recent spinal cord injury (SCI) as well as the effect of antiosteoporotic therapy with denosumab in these bone regulators in a prospective study.Patients and methods: Twenty-three male patients (aged 18–67 years (mean 36±16 years)) with recent (<6 months) complete SCI were prospectively included (43.5% parapl...

ba0005p488 | Preclinical and ex vivo imaging | ECTS2016

Mandibular bone: an unusual trabecular bone?

Coutel Xavier , Olejnik Cecile , Marchandise Pierre , Chauveau Christophe , Penel Guillaume

Introduction: Mandibular alveolar bone appears to be particularly sensitive to local factors compared to other skeletal sites. In growing rats, occlusal hypofunction leads to a dramatic decrease of the alveolar bone microarchitecture. Intra-radicular bone surrounding teeth is a specific functional area with a high bone turnover. We hypothesized that the mechanical loading of the alveolar process during mastication may play a role in the preservation of the alveolar bone microa...

ba0001pp89 | Bone development/growth and fracture repair | ECTS2013

Spirulina alga prevents impairment of peak bone mass acquisition induced by an isocaloric low protein diet

Fournier Carole , Rizzoli Rene , Ammann Patrick

New food strategies should be developed to fight against child malnutrition and growth retardation in developing countries. Spirulina alga, one of the richest sources of vegetable protein, contains all essential amino acids. It easily grows in tropical regions. We hypothesized that impaired peak bone mass acquisition (PBMA) caused by dietary protein deficiency could be prevented by Spirulina supplementation in growing rats.One-month old female rats were ...

ba0001pp377 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship to bone turnover and bone mass

Gifre Laia , Peris Pilar , Ruiz-Gaspa Silvia , Monegal Ana , Nomdedeu Benet , Guanabens Nuria

Wnt–β-catenin signalling and its antagonists (sclerostin and Dkk-1) play an important role in the regulation of bone mass and osteoblastogenesis. Glucocorticoid therapy (GCCT) is a well known factor related to decreased bone formation and osteoporosis development. Therefore, we analyzed the effect of GCCT on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship to bone mass and bone turnover.Methods: 22 patients (11M/11F, age...

ba0003pp75 | Bone development/growth and fracture repair | ECTS2014

Low calcium-phosphate diet attenuates dietary protein deficiency-mediated impairment of bone growth by blunting the decrease in serum IGF1 and in hepatic GH receptor gene expression

Fournier Carole , Rizzoli Rene , Ammann Patrick

Low protein diet (LPD) impairs body growth, decreases serum IGF1 and increases serum FGF21, two hepatokines influencing bone growth. Low calcium-phosphate diet (LCaPiD) increases serum calcitriol. We hypothesized that LPD effects on bone growth may differ according to calcium and phosphate intakes through the hormonal modulation of calcitriol, IGF1 and FGF21. One-month old rats were fed isocaloric diets containing 10 or 5% casein (10Prot, 5Prot), with 1.0% calcium and 0.8% pho...

ba0003pp251 | Osteoporosis: evaluation and imaging | ECTS2014

The ability of quantitative ultrasound variables to identify osteoporosis in various regions of interest in female corticosteroid users

Sindel Dilsad , Ketenci Aysegul , Yaliman Ayse , Aydin Tugba , Koseoglu Pinar Kursuz , Oral Aydan

The objective of this study was to evaluate the ability of various quantitative ultrasound variables to discriminate osteoporotic female corticosteroid users. Thirty-two women aged between 26 and 79 years who have been receiving corticosteroids equivalent to a minimum of 5 mg daily prednisolone for more than 3 months underwent bone mineral density (BMD) measurements at the lumbar spine, hip, and one-third radius (33% radius) using dual-energy X-ray absorptiometry (DXA). Acoust...

ba0004p118 | (1) | ICCBH2015

Changes in total body and regional bone mass in relation to body composition in children with osteogenesis imperfecta treated with pamidronate

Sritharan Shironisha , Gopal-Kothandapani Jaya Sujatha , Bishop Nick , Dimitri Paul

Background: In patients with osteogenesis imperfecta (OI), a rise in age-specific total body and regional bone mass is well recognised. In contrast changes in body size-adjusted bone mass in relation to changes in body composition following pamidronate therapy remain relatively unexplored.Methods: Changes in total and regional bone mass in relation to body composition in children with OI receiving pamidronate (3 mg/kg per day over 3 days, 3 monthly) were...

ba0005ht3 | (1) | ECTS2016

Deletion of protease-activated receptor-2 improves bone and muscle pathology in dystrophin-deficient (mdx) mice

Esfandouni Neda Taghavi , Sanaei Reza , Samuel Chrishan , Pagel Charles , Mackie Eleanor

Duchenne muscular dystrophy (DMD) is associated with osteoporosis, and dystrophic (dystrophin-deficient) mdx mice show reduced bone mass characterised by decreased mineral apposition and elevated bone resorption. To investigate a potential role of the G-protein-coupled receptor protease-activated receptor-2 (PAR2) in the muscle and bone pathology associated with DMD, we established a colony of PAR2-null-mdx mice. Limb and diaphragm muscles, tibiae and ser...